| 摘要 |
<p>The present invention is related to pharmaceutical formulations comprising tricyclo[3.3.1.13,7 ]decan-1-amine,3,5-dimethyl hydrochloride that shall be used in the treatment of Alzheimer's disease and dementia. Said formulations are characterized in being in effervescent form.</p> |
